vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Community West Bancshares (CWBC). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $38.3M, roughly 1.6× Community West Bancshares). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs 8.1%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-1.8M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Community West BancsharesCWBCEarnings & Financial Report
Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.
CTKB vs CWBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $38.3M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 40.0% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 11.6% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $38.3M | ||
| Q3 25 | $52.3M | $37.9M | ||
| Q2 25 | $45.6M | $35.7M | ||
| Q1 25 | $41.5M | $34.8M | ||
| Q4 24 | $57.5M | $34.3M | ||
| Q3 24 | $51.5M | $31.3M | ||
| Q2 24 | $46.6M | $30.5M | ||
| Q1 24 | $44.9M | $20.7M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $10.9M | ||
| Q2 25 | $-5.6M | $7.8M | ||
| Q1 25 | $-11.4M | $8.3M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $3.4M | ||
| Q2 24 | $-10.4M | $-6.3M | ||
| Q1 24 | $-6.2M | $3.7M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 40.0% | ||
| Q3 25 | -17.6% | 39.8% | ||
| Q2 25 | -23.3% | 30.2% | ||
| Q1 25 | -36.1% | 32.7% | ||
| Q4 24 | 5.2% | 31.0% | ||
| Q3 24 | -8.2% | 13.3% | ||
| Q2 24 | -18.3% | -25.9% | ||
| Q1 24 | -23.9% | 23.2% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 28.7% | ||
| Q2 25 | -12.2% | 22.0% | ||
| Q1 25 | -27.5% | 23.8% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 10.8% | ||
| Q2 24 | -22.4% | -20.7% | ||
| Q1 24 | -13.8% | 17.8% |
| Q4 25 | — | $0.58 | ||
| Q3 25 | — | $0.57 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | — | $0.44 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | — | $0.18 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $119.0M |
| Total DebtLower is stronger | — | $69.5M |
| Stockholders' EquityBook value | $341.7M | $409.6M |
| Total Assets | $461.5M | $3.7B |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $119.0M | ||
| Q3 25 | $93.3M | $121.6M | ||
| Q2 25 | $75.5M | $134.4M | ||
| Q1 25 | $95.3M | $148.4M | ||
| Q4 24 | $98.7M | $120.4M | ||
| Q3 24 | $162.3M | $149.0M | ||
| Q2 24 | $177.9M | $109.7M | ||
| Q1 24 | $168.8M | $61.0M |
| Q4 25 | — | $69.5M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $69.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $409.6M | ||
| Q3 25 | $378.6M | $397.6M | ||
| Q2 25 | $377.6M | $380.0M | ||
| Q1 25 | $379.6M | $372.2M | ||
| Q4 24 | $395.7M | $362.7M | ||
| Q3 24 | $385.5M | $363.5M | ||
| Q2 24 | $389.1M | $350.2M | ||
| Q1 24 | $392.6M | $211.7M |
| Q4 25 | $461.5M | $3.7B | ||
| Q3 25 | $494.9M | $3.6B | ||
| Q2 25 | $493.3M | $3.6B | ||
| Q1 25 | $482.6M | $3.6B | ||
| Q4 24 | $499.5M | $3.5B | ||
| Q3 24 | $491.2M | $3.5B | ||
| Q2 24 | $483.7M | $3.5B | ||
| Q1 24 | $492.1M | $2.4B |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $46.1M |
| Free Cash FlowOCF − Capex | $-1.8M | $43.6M |
| FCF MarginFCF / Revenue | -2.9% | 113.9% |
| Capex IntensityCapex / Revenue | 1.6% | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $77.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $46.1M | ||
| Q3 25 | $-3.9M | $13.2M | ||
| Q2 25 | $108.0K | $11.5M | ||
| Q1 25 | $-125.0K | $11.1M | ||
| Q4 24 | $2.0M | $22.2M | ||
| Q3 24 | $13.2M | $7.8M | ||
| Q2 24 | $6.2M | $5.2M | ||
| Q1 24 | $4.0M | $4.0M |
| Q4 25 | $-1.8M | $43.6M | ||
| Q3 25 | $-4.6M | $12.8M | ||
| Q2 25 | $-1.5M | $10.6M | ||
| Q1 25 | $-974.0K | $10.8M | ||
| Q4 24 | $1.1M | $17.2M | ||
| Q3 24 | $12.2M | $5.2M | ||
| Q2 24 | $5.2M | $4.8M | ||
| Q1 24 | $3.4M | $3.6M |
| Q4 25 | -2.9% | 113.9% | ||
| Q3 25 | -8.7% | 33.7% | ||
| Q2 25 | -3.2% | 29.6% | ||
| Q1 25 | -2.3% | 30.9% | ||
| Q4 24 | 1.9% | 50.0% | ||
| Q3 24 | 23.7% | 16.7% | ||
| Q2 24 | 11.0% | 15.7% | ||
| Q1 24 | 7.6% | 17.3% |
| Q4 25 | 1.6% | 6.6% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 3.5% | 2.7% | ||
| Q1 25 | 2.0% | 0.9% | ||
| Q4 24 | 1.6% | 14.7% | ||
| Q3 24 | 2.0% | 8.1% | ||
| Q2 24 | 2.3% | 1.4% | ||
| Q1 24 | 1.3% | 2.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.21× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 2.29× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
CWBC
Segment breakdown not available.
